The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
T Cell-Specific siRNA Delivery Suppresses HIV-1 Infection in Humanized Mice
Open accessAbstract
SUMMARY Evaluation of the therapeutic potential of RNAi for HIV infection has been hampered by the challenges of siRNA delivery and lack of suitable animal models. Using a novel delivery method in humanized mice, we show that siRNA treatment can dramatically suppress HIV infection. A CD7-specific single-chain antibody was conjugated to oligo-9-arginine peptide (scFvCD7-9R) for T cell-specific siRNA delivery in NOD/SCIDIL2rγ−/− mice reconstituted with human lymphocytes (Hu-PBL) or CD34+ hematopoietic stem cells (Hu-HSC). In HIV-infected Hu-PBL mice, treatment with anti-CCR5 and antiviral siRNAs complexed to scFvCD7-9R controlled viral replication and prevented the disease-associated CD4 T cell loss. This treatment also suppressed endogenous virus and restored CD4 T cell counts in mice reconstituted with HIV+ PBMC. Moreover, scFvCD7-9R could deliver antiviral siRNAs to naïve T cells in Hu-HSC mice and effectively suppress viremia in infected mice. Thus, siRNA therapy for HIV infection appears to be feasible in a preclinical animal model.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Finzi, D., Blankson, J., Siliciano, J. D., Margolick, J. B., Chadwick, K., Pierson, T., Smith, K., Lisziewicz, J., Lori, F., Flexner, C., et al. (1999) · Nature Medicine · doi:10.1038/8394 · Cited by 2,119
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways
Grimm, D., Streetz, K. L., Jopling, C. L., Storm, T. A., Pandey, K., Davis, C. R., Marion, P., Salazar, F., & Kay, M. A. (2006) · Nature · doi:10.1038/nature04791 · Cited by 1,677
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Self-citationRNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
Self-citationMiR-150 Controls B Cell Differentiation by Targeting the Transcription Factor c-Myb
Xiao, C., Calado, D. P., Galler, G., Thai, T.-H., Patterson, H. C., Wang, J., Rajewsky, N., Bender, T. P., & Rajewsky, K. (2007) · Cell · doi:10.1016/j.cell.2007.07.021 · Cited by 1,042
Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors
Song, E., Zhu, P., Lee, S.-K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., et al. (2005) · Nature Biotechnology · doi:10.1038/nbt1101 · Cited by 1,021
Self-citationDevelopment of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
Ishikawa, F., Yasukawa, M., Lyons, B., Yoshida, S., Miyamoto, T., Yoshimoto, G., Watanabe, T., Akashi, K., Shultz, L. D., & Harada, M. (2005) · Blood · doi:10.1182/blood-2005-02-0516 · Cited by 932
Self-citationsiRNA-directed inhibition of HIV-1 infection
Novina, C. D., Murray, M. F., Dykxhoorn, D. M., Beresford, P. J., Riess, J., Lee, S.-K., Collman, R. G., Lieberman, J., Shankar, P., & Sharp, P. A. (2002) · Nature Medicine · doi:10.1038/nm725 · Cited by 773
Self-citationGene transfer in humans using a conditionally replicating lentiviral vector
Levine, B. L., Humeau, L. M., Boyer, J., MacGregor, R.-R., Rebello, T., Lu, X., Binder, G. K., Slepushkin, V., Lemiale, F., Mascola, J. R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608138103 · Cited by 501
miRNA Profiling of Naïve, Effector and Memory CD8 T Cells
Wu, H., Neilson, J. R., Kumar, P., Manocha, M., Shankar, P., Sharp, P. A., & Manjunath, N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001020 · Cited by 480
Self-citationCaron, G., Duluc, D., Frémaux, I., Jeannin, P., David, C., Gascan, H., & Delneste, Y. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.3.1551 · Cited by 410
Silencing of HIV-1 with RNA Interference: a Multiple shRNA Approach
ter Brake, O., Konstantinova, P., Ceylan, M., & Berkhout, B. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.07.007 · Cited by 293
The growth and potential of human antiviral monoclonal antibody therapeutics
Marasco, W. A., & Sui, J. (2007) · Nature Biotechnology · doi:10.1038/nbt1363 · Cited by 284
Peer, D., Zhu, P., Carman, C. V., Lieberman, J., & Shimaoka, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608491104 · Cited by 275
Kim, W. J., Christensen, L. V., Jo, S., Yockman, J. W., Jeong, J. H., Kim, Y.-H., & Kim, S. W. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.022 · Cited by 251
Self-citationHamamoto, K., Kida, Y., Zhang, Y., Shimizu, T., & Kuwano, K. (2002) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2002.tb02759.x · Cited by 242
Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition
Brake, O. T., Hooft, K. '., Liu, Y. P., Centlivre, M., Jasmijn von Eije, K., & Berkhout, B. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300382 · Cited by 239
Rossi, J. J., June, C. H., & Kohn, D. B. (2007) · Nature Biotechnology · doi:10.1038/nbt1367 · Cited by 231
Song, E., Lee, S.-K., Dykxhoorn, D. M., Novina, C., Zhang, D., Crawford, K., Cerny, J., Sharp, P. A., Lieberman, J., Manjunath, N., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7174-7181.2003 · Cited by 230
Self-citationSurabhi, R. M., & Gaynor, R. B. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.12963-12973.2002 · Cited by 203
HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-γc-/-(RAG-hu) mouse model
Berges, B. K., Wheat, W. H., Palmer, B. E., Connick, E., & Akkina, R. (2006) · Retrovirology · doi:10.1186/1742-4690-3-76 · Cited by 171
Banerjea, A., Li, M.-J., Bauer, G., Remling, L., Lee, N.-S., Rossi, J., & Akkina, R. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00140-0 · Cited by 166
Berges, B. K., Akkina, S. R., Folkvord, J. M., Connick, E., & Akkina, R. (2008) · Virology · doi:10.1016/j.virol.2007.11.020 · Cited by 144
Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway
John, M., Constien, R., Akinc, A., Goldberg, M. S., Moon, Y.-A., Spranger, M., Hadwiger, P., Soutschek, J., Vornlocher, H., Manoharan, M., et al. (2007) · Nature · doi:10.1038/nature06179 · Cited by 144
The prospect of silencing disease using RNA interference.
Shankar, P., Manjunath, N., & Lieberman, J. (2005) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.293.11.1367 · Cited by 141
Self-citationHuman Immunodeficiency Virus Type 1 Pathobiology Studied in Humanized BALB/c-Rag2 −/− γ c −/− Mice
Gorantla, S., Sneller, H., Walters, L., Sharp, J. G., Pirruccello, S. J., West, J. T., Wood, C. A., Dewhurst, S., Gendelman, H. E., & Poluektova, L. Y. (2006) · Journal of Virology · doi:10.1128/jvi.02010-06 · Cited by 135
von Eije, K. J., ter Brake, O., & Berkhout, B. (2007) · Journal of Virology · doi:10.1128/jvi.02035-07 · Cited by 124
Off-targeting and other non-specific effects of RNAi experiments in mammalian cells.
Svoboda, P. (2007) · PubMed · Cited by 112
Anderson, J. S., Li, M.-J., Palmer, B. E., Remling‐Mulder, L., Li, S. X., Yam, P. Y., Yee, J., Rossi, J. J., Zaia, J. A., & Akkina, R. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300157 · Cited by 111
Lee, S., Dykxhoorn, D. M., Kumar, P., Ranjbar, S., Song, E., Maliszewski, L. E., François-Bongarçon, V., Goldfeld, A. E., Swamy, N. M., Lieberman, J., et al. (2005) · Blood · doi:10.1182/blood-2004-10-3959 · Cited by 105
Self-citationBremer, E., Samplonius, D. F., Peipp, M., van Genne, L., Kroesen, B., Fey, G. H., Gramatzki, M., de Leij, L. F. M. H., & Helfrich, W. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2756 · Cited by 90
Self-citationWatanabe, S., Ohta, S., Yajima, M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01353-07 · Cited by 85
Frankel, A. E., Laver, J. H., Willingham, M. C., Burns, L. J., Kersey, J. H., & Vallera, D. A. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709051778 · Cited by 84
Progress and prospects: RNA-based therapies for treatment of HIV infection
Scherer, L. J., Rossi, J. J., & Weinberg, M. S. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302977 · Cited by 81
Peipp, M., Küpers, H., Saul, D., Schlierf, B., Greil, J., Zunino, S. J., Gramatzki, M., & Fey, G. H. (2002) · PubMed · Cited by 70
Self-citationEfficient nonviral gene delivery into primary lymphocytes from rats and mice
Goffinet, C., & Keppler, O. T. (2006) · The FASEB Journal · doi:10.1096/fj.05-4651fje · Cited by 60
Nakata, H., Maeda, K., Miyakawa, T., Shibayama, S., Matsuo, M., Takaoka, Y., Ito, M., Koyanagi, Y., & Mitsuya, H. (2005) · Journal of Virology · doi:10.1128/jvi.79.4.2087-2096.2005 · Cited by 59
Hogrefe, R. I., Lebedev, A. V., Zon, G., Pirollo, K. F., Rait, A. S., Zhou, Q., Yu, W., & Chang, E. H. (2006) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770600793885 · Cited by 56
Fais, S., Lapenta, C., Santini, S. M., Spada, M., Parlato, S., Logozzi, M., Rizza, P., & Belardelli, F. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6453-6459.1999 · Cited by 48
A protocol for PAIR: PNA-assisted identification of RNA binding proteins in living cells
Zeng, F., Peritz, T., Kannanayakal, T. J., Kilk, K., Eiríksdóttir, E., Langel, Ü., & Eberwine, J. H. (2006) · Nature Protocols · doi:10.1038/nprot.2006.81 · Cited by 46
Lazarovits, A. I., Rochon, J., Banks, L., Hollomby, D. J., Muirhead, N., Jevnikar, A. M., White, M. J., Amlot, P. L., Beauregard-Zollinger, L., & STILLER, C. R. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.11.5163 · Cited by 43
Targeted gene disruption of murine CD7
Bonilla, F. A. (1997) · International Immunology · doi:10.1093/intimm/9.12.1875 · Cited by 41
Interfering antiviral immunity: application, subversion, hope?
Manjunath, N., Kumar, P., Lee, S. K., & Shankar, P. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.05.006 · Cited by 20
Self-citation
Cited by
The current state and future directions of RNAi-based therapeutics
Setten, R. L., Rossi, J. J., & Han, S.-P. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0017-4 · Cited by 1,443
Therapeutic targeting of microRNAs: current status and future challenges
Li, Z., & Rana, T. M. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4359 · Cited by 1,033
Humanized mice for immune system investigation: progress, promise and challenges
Shultz, L. D., Brehm, M. A., Garcia-Martinez, J. V., & Greiner, D. L. (2012) · Nature Reviews Immunology · doi:10.1038/nri3311 · Cited by 979
Self-citationThe delivery of therapeutic oligonucleotides
Juliano, R. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw236 · Cited by 854
Tuberculosis and HIV Co-Infection
Pawlowski, A., Jansson, M., Sköld, M., Rottenberg, M. E., & Källenius, G. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002464 · Cited by 764
Metadata
- Authors
- Kumar, P., Ban, H.-S., Kim, S.-S., Wu, H., Pearson, T., Greiner, D. L., Laouar, A., Yao, J., Haridas, V., Habiro, K., Yang, Y.-G., Jeong, J.-H., Lee, K.-Y., Kim, Y.-H., Kim, S. W., Peipp, M., Fey, G. H., Manjunath, N., Shultz, L. D., Lee, S.-K., & Shankar, P.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 134
- Issue
- 4
- Pages
- 577-586
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2117698690
- Cited by
- 570
- References
- 44
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.